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Pathologically swollen lymph nodes (LNs), or buboes,
characterize Yersinia pestis infection, yet how they
form and function is unknown. We report that coloni-
zation of the draining LN (dLN) occurred due to traf-
ficking of infected dendritic cells and monocytes in
temporally distinct waves in response to redundant
chemotactic signals, including through CCR7, CCR2,
and sphingosine-1-phospate (S1P) receptors. Reten-
tion of multiple subsets of phagocytes within periph-
eral LNs using the S1P receptor agonist FTY720 or
S1P1-specific agonist SEW2871 increased survival,
reduced colonization of downstream LNs, and limited
progression to transmission-associated septicemic
or pneumonic disease states. Conditional deletion of
S1P1 in mononuclear phagocytes abolished node-
to-node trafficking of infected cells. Thus, Y. pestis-
orchestrated LN remodeling promoted its dissemina-
tion via host cells through the lymphatic system but
can be blocked by prevention of leukocyte egress
from DLNs. These findings define a novel trafficking
route of mononuclear phagocytes and identify S1P
as a therapeutic target during infection.
INTRODUCTION
Yersinia pestis is a Gram-negative bacterial pathogen that is
responsible for more human deaths, historically, than any
other infectious agent. As such, it constitutes a remarkable
example where the mammalian immune system profoundly
fails to contain infection within the host or subsequent spread
within a population. After deposition of infectious bacteria
subcutaneously by fleas, the most common route of exposure
(Hinnebusch, 2005), disease is characterized by the formation
of buboes, lymph nodes (LNs) that are swollen far beyond the
degree that occurs with LN hypertrophy during the initiation440 Immunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc.of productive immunity (Butler, 1994; Perry and Fetherston,
1997). The virulence of Y. pestis has always been assumed
to be dependent on the ability of this pathogen to enter the
draining LNs (dLNs); however, little is known about the mech-
anisms of bubo formation or the utility of these pathological
structures to the progression of disease systemically (Perry
and Fetherston, 1997). Uncontained infection frequently pro-
gresses rapidly from bubonic plague, where the dLN is the
predominate organ affected, beyond the initial site of infection
to systemic forms affecting the blood (septicemic plague)
or the lungs (pneumonic plague). Both of these more clinically
serious disease states are associated with further bacterial
spread to new hosts (Jawetz and Meyer, 1944; Perry and Fe-
therston, 1997). It is unknown, however, what route the
bacteria take to establish systemic infection. In particular,
the role played by the progressive development of buboes in
the host is not understood, as is whether these structures
are functional effectors of disease or merely evidence of dis-
ease as the host attempts to mount a protective adaptive im-
mune response within LNs in the presence of considerable
pathogen burden. Several notable bacterial pathogens are
lymphotrophic, including Salmonella Typhimurium, which is
closely related to Y. pestis, and others (Bar-Haim et al.,
2008; St John and Abraham, 2009), but little of the mecha-
nistic utility of targeting lymphoid tissue has been experimen-
tally investigated.
We began these studies with the aim of elucidating the
underlying basis of bubo formation and its contributions to
Y. pestis virulence and in vivo trafficking in order to reveal in
greater detail how the LN microenvironment responds to a sub-
stantial bacterial challenge. Our findings show that Y. pestis in-
fects cell types including dendritic cells (DCs) and mononuclear
phagocytes and exploits the trafficking routes of these cells
to achieve systemic infection. Transit of Y. pestis-infected
cells between LNs via the lymphatic system was shown to
be dependent on Sphingosine-1-phosphate (S1P). These re-
sults demonstrate the importance of mononuclear phagocytes
to the pathogenesis of bubonic plague and define a new
trafficking route for monocytic cells that can occur during
infection.
Figure 1. Buboes Contain Intracellular
Y. pestis
(A) H&E-stained LN sections, 24 hr after injection
of saline or 1 3 105 CFU of the designated bac-
teria, illustrate the distinction between a normal
hypertrophic LN (E. coli) and the early stages of a
bubo (Y. pestis). Image was obtained at 103
magnification.
(B) A LN sinus from the medullary region of an
H&E-stained LN, 24 hr after infection of Y. pestis
(403 magnification).
(C) Intracellular rod-shaped bacilli are visible
within a LN (left), imaged by TEM, 72 hr after
Y. pestis injection in the footpad. The right panel is
a lower magnification of this area demonstrating
that the infected cell is morphologically consistent
with a macrophage.
Images are representative of R2 independent
experiments.
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Infected Cellular Compartments of LNs during Y. pestis
Infection
To begin our investigation of the mechanism of bubo formation,
we infected mice with Y. pestis subcutaneously in their rear foot-
pads to replicate the natural route of infection prior to the infiltra-
tion of the dLN. The footpad also has the advantage of being
drained by a single sentinel LN, the popliteal node. We injected
1 3 105 CFU of Y. pestis Kim5 (hereafter referred to only as
Y. pestis), a strain that retains all of its virulence factors but lacks
the ‘‘pigmentation locus,’’ which facilitates iron acquisition (Bru-
baker et al., 1965; Perry et al., 1990). As a result, these bacteria
have slower growth in vivo than wild-type Y. pestis, allowing the
initial stages of disease progression to be studied temporally. To
begin, we sought to recapitulate within our model the character-
istic dLN pathology that is observed clinically (Butler, 1994). Dur-
ing E. coli infection, which, in contrast, is quickly cleared in mice,
dLNs swelled in sizewith the retention of greater numbers of lym-
phocytes from the circulation, so that at 24 hr postinfection the
dLNs may have doubled in size (Figure 1A; McLachlan et al.,
2003). In contrast, Y. pestis-infected dLNs surpassed the size
of dLNs responding to E. coli infection and displayed a charac-
teristic pathology with swollen sinuses, or sinus histiocytosis
(Figure 1A). Similar to reports of clinical infection and models
of infection with WT Y. pestis (McLachlan et al., 2003; Sebbane
et al., 2005), mice had progressive bubo formation, character-
ized by necrotic lesions that were visible beginning around
24 hr after infection, based on staining of sections with propi-
dium iodide (Figure S1 available online). The areas of necrosis
progressively grew, often constituting large regions of the DLN
by 72 hr after infection (Figure S1). Careful examination of
swollen dLN sinuses 24 hr after Y. pestis infection revealed
that they are full of cellular infiltrates that are histologically
consistent with macrophages (Figure 1B). We also observed
by transmission electron microscopy (TEM) that many of theseImmunity 41, 440–450, Secells contained individual or multiple bac-
teria within vesicular compartments (Fig-
ure 1C), consistent with previous findingsthat macrophages can be infected and that viable Y. pestis is
frequently found intracellularly in vivo (Cavanaugh and Randall,
1959; Finegold, 1969; Janssen and Surgalla, 1969; Marketon
et al., 2005; Straley and Harmon, 1984). These observations indi-
cate that Y. pestis-induced buboes contain massive infiltrates of
macrophages, many of them harboring intracellular bacteria.
Multiple phagocytic cell types can be infected by Y. pestis,
including macrophages and DCs (Cavanaugh and Randall,
1959; Saikh et al., 2004; Zhang et al., 2008). After observing intra-
cellular bacteria within dLNs by TEM (Figure 1C), we investigated
the phenotype of the infected cells in order to determine which
cellular compartments were infected within dLNs over a time
course of bubo formation.We expressed orange fluorescent pro-
tein (YP-OFP) in Y. pestis (YP-OFP), which allowed us to subject
single-cell suspensions of dLNs to surface staining for cellular
markers, followed by flow cytometry to define the populations
containing intracellular bacteria. We also verified that OFP
expression did not alter the kinetics of bacterial spread in vivo
(data not shown). At 6 hr after injection of bacteria into the foot-
pads, more than 90% the infected cells within the dLN were
predominately double positive (DP) for CD11c and CD11b (Fig-
ure 2A). At the same time, bacteria were not detected inside
CD11b+CD11c cells (Figure 2A), which correspond broadly to
a non-DC monocyte or macrophage cell type (Geissmann et al.,
2003). By 24 hr after infection, YP-OFP could be detected inside
these CD11b+ single-positive (SP) cells, and the percentage of
CD11b+ SP infected cells gradually increased over the course
of the next days, becoming approximately equivalent in numbers
to the percentage of infected cells thatwereCD11c+CD11b+DCs
by around 48 hr after infection, and surpassing them to become
the predominately infected cell type by 72 hr (Figure 2A). The per-
centage of infected cells was also consistent with the trend for to-
tal numbers of infected cells in the dLN,which increased themost
over the initial 24 hr of infection (Figure S2A). To further define the
cell types that were infected phenotypically, we performed flow
cytometry after staining using a full panel of myeloid cell markers.ptember 18, 2014 ª2014 Elsevier Inc. 441
Figure 2. Two Waves of Infected Cellular Compartments within dLNs
(A) The relative phenotype of infected cells within dLNs based on staining for surface markers CD11c and CD11b as a percentage of total infected cells,
determined by flow cytometry using YP-OFP to detect infected cells (nR 3). Populations of single-positive (SP) and double-positive (DP) cells for eachmarker are
presented. Abbreviation: ND, not detected. For corresponding total cell numbers see Figure S2A.
(B) Percentages of YP-OFP+ cells according to phenotype 24 hr after infection after footpad infection with 53 105 YP-OFP. n = 5; data are representative of two
independent experiments.
(C) Subsets of infected DCs (OFP+CD11c+IA/IE+) defined by flow cytometry as a percentage of total infected DCs.
(D) The total numbers of iMono,moDC, and PMNs in either YP-OFP-infected or resting LNswere determined by flow cytometry at 24 hr. Data are representative of
two independent experiments with n = 5. The ratio of each cell type is presented above the corresponding bars: resting:infected.
For (B)–(D), gating strategies are included as in Figures S2C and S2D.
(E) LN sections at 24 and 72 hr show a shift in the phenotype of the predominately infected cell (containing YP-OFP, red) from CD11c+ (green) to CD11c. In both
images at least some infected cells appear to be CD11b+ (blue). All images are representative of three or more independent experiments with n R 3. Coloc-
alization images are provided in Figure S2E.
(F) Real-time PCR was performed to quantify mRNA levels for the chemokines CCL2, CCL3, CCL4, and CXCL10 present in LNs infected with E. coli, S.
Typhimurium, or Y. pestis. Data are representative of three independent experiments performed with RNA from individual LNs at each time point. For a time
course of chemokine production in dLNs, see Figure S2E.
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LN DCs (CD11c+IA/IE+) as well as neutrophils (PMN, Ly6Ghi) and,
to a lesser extent, inflammatory monocytes (iMono; CD11b+
LY6C+F4/80+IA/IE) (Figure 2B). We further defined the infected
DC populations and observed that most infected DCs were
CD11b+, with much smaller populations of CD11b DCs and
monocyte-derived DCs (moDC; CD11c+CD11b+IA/IE+Ly6C+)
also containing intracellular Y. pestis (Figure 2C). Examining total
cells, we observed substantial infiltration of iMono, moDCs, and
neutrophils compared to resting conditions (Figure 2D). To further
support that intracellular OFP-expressing Y. pestis were con-
tainedwithinmyeloid cells,we conjugated thesebacteria tomag-
netic particles prior to infection of footpads, using an established
protocol (Lo¨nnbro et al., 2008). At 24 hr after infection, LNs were
harvested and prepared as single-cell suspensions. When the
bacteriawithin thepreparationsweremagnetically isolated, intra-
cellular bacteria were recovered that were contained within cells
staining positive for myeloid markers (Figure S2B). By confocal442 Immunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc.microscopy, we could visualize the colocalization of OFP with
CD11band/orCD11cwithin sectionedandstainedLN tissue (Fig-
ures 2E and S5). Bacteria were seen inside cells expressing
CD11c and CD11b at the 24 hr time point (Figures 2E and S4).
Consistentwithour flowcytometrydata, at 72hr,OFPcolocalized
primarily with CD11b+ cells, but colocalization with CD11c stain-
ing was often not detectable (Figures 2E and S5). Cumulatively,
these flowcytometry and fluorescentmicroscopy results suggest
that there are two distinct waves of infection within dLNs, the first
primarily of DCs,which are known tomigrate from sites of periph-
eral inflammation to the dLNearly after cutaneous infection (Shel-
burne et al., 2009), and the second of non-DCmyeloid cells, likely
to be monocytes, macrophages, and neutrophils.
Directed Migration of DCs and Monocytes Enhances
dLN Infection
Features of Y. pestis infection are the progression of dLN pathol-
ogy beyond the normal extent of LN hypertrophy that is induced
Immunity
S1P-Dependent Trafficking of Yersinia pestisduring similar infections (Figure 1A) and the transition of the
cellularity of the LN structure to a profile characterized by the
marked increase of CD11b+ non-DC cell types within dLNs,
which is significant by 24 hr after infection (Figure 2A). We
hypothesized that there might be changes in chemokine expres-
sion within dLNs that could promote the mass influx of macro-
phages that is observed during Y. pestis infection. Therefore,
we harvested dLNs from mice infected as described above
and isolated RNA to determine the expression of several chemo-
kines that are able to recruit multiple subsets of monocytes and
macrophages (Charo and Ransohoff, 2006; Proudfoot, 2002). By
real-time PCR, we determined substantial increases in the
expression of chemokines, including CCL2, CCL3, CCL4, and
CXCL10 (also known as MCP-1, MIP-1a, MIP-1b, and IP-10,
respectively) within dLNs with Y. pestis infection, compared to
saline controls (Figures 2F and S6). Each of these chemokines
has a well-established role in the recruitment of monocytes,
DCs, and/or macrophages (Cross et al., 1997; Shi and Pamer,
2011). In order to compare Y. pestis-induced chemokine in-
creases within the context of other infections, we also examined
the chemokine production in LNs to two other Gram-negative
pathogens, Escherichia coli (where infection remains confined
to the site of infection) and Salmonella Typhimurium (which
has well-established dLN-targeting adaptations) (St John and
Abraham, 2009). These additional bacterial pathogens also
induced subtle increases in the expression of chemokines within
dLNs over saline injection; however, the increases were far
below the drastic changes in chemokine expression evoked by
Y. pestis (Figure 2F). Thus, an overabundance of monocyte
and macrophage chemoattractants in dLNs characterizes
Y. pestis infection, resulting in the arrival of a broad panel of cells
permissive to infection or already-infected cells from the site of
infection.
Based on the observations that large numbers of infected cells
within dLNs are migratory phagocytes and that chemoattrac-
tants for these cells are broadly upregulated in the first 24 hr of
infection, we aimed to directly test the contributions of cellular
trafficking to containment or enhancement of Y. pestis infection.
CCR2-deficient mice were chosen since this chemokine recep-
tor has been shown to direct chemotaxis into sites of inflamma-
tion, toward CCL2 (Geissmann et al., 2003; Lin et al., 2008),
which is one of the chemokines that is expressed more abun-
dantly in Y. pestis-infected dLNs than other infections we exam-
ined (Figure 2F). In mice infected with Y. pestis, we observed that
a subset of inflammatory monocytes (which have been identified
by others based on their CCR2-directed migration [Geissmann
et al., 2003; Lin et al., 2008]) were reduced in numbers in the
dLNs of Ccr2/mice compared to WT mice, where recruitment
into the dLN of cells expressing both F4/80 and CD11b was
impaired (Figure S3). However, a population of cells expressing
CD11b alone still infiltrated, although they appeared to be largely
confined to the dLN sinuses (Figure S3). Next, we quantified the
numbers of bacteria within dLNs at 24 hr inCcr2/ andWTmice
to determine whether CCR2 could influence the numbers of bac-
teria in the dLN. Mice were infected in their footpads, as above,
and dLNs were harvested after 24 hr. Although the absence of
this chemokine receptor did not entirely abolish intracellular
bacteria within dLNs, we found that Ccr2/ mice had sig-
nificantly reduced numbers of Y. pestis-infected cells in theirImdLNs compared to WT mice (Figure 3A). Thus, the infiltration of
inflammatory monocytes into the dLN contributes to the ability
of Y. pestis to replicate within or spread to the dLN.
CCR2 is only one of many chemokine receptors having the po-
tential to directmonocytemigration to the dLNs, but the first cells
to be infected there appeared to be DCs (Figures 2A, 2C, and
2D), which largely migrate very early after activation (within hours
of peripheral E. coli infection) (Shelburne et al., 2009) and in
response to a constitutive chemotactic gradient of CCL21 (Ran-
dolph et al., 2005). Therefore, we also investigated whether mice
lacking the receptor for CCL21, CCR7, had fewer bacteria within
DLNs during Y. pestis infection. Although a caveat of use of these
mice is that they have additional alterations to LN morphology,
including compartmentalization of T cells, they have greatly
reduced LN-homing capacity of DCs (Fo¨rster et al., 1999).
Notably, the background strains of CCR7-deficient and CCR2-
deficient mice vary in these experiments (BALB/c and C57BL/
6, respectively), which is known to influence the kinetics and
tolerance of Y. pestis infection in mice (Turner et al., 2008).
Therefore, we optimized the dose of Y. pestis required for lethal
infection and Ccr7/ mice and BALB/c controls were adminis-
tered a larger inoculating dose of 1 3 107 CFU in footpads. In
Ccr7/ mice, similarly to Ccr2/ mice, intracellular Y. pestis
were reduced in dLNs by 24 hr, compared to controls, as deter-
mined by flow cytometry (Figure 3B). We also observed that
localized pretreatment of wild-type mice (C57BL/6) with a
neutralizing antibody against CCL21 within the footpad substan-
tially reduced the increased CCL2 expression that was observed
in LNs at 24 hr after infection compared to administration of an
isotype control antibody (Figure 3C). As expected, CCL21
neutralization also decreased the number of CD11c+ DCs within
Y. pestis-infected LNs at 24 hr (Figure 3D) and the CFU of
Y. pestis in the dLN at 24 hr (Figure 3E), emphasizing the role
of early DC trafficking in both bacterial invasion of dLNs and in
prompting the subsequent chemokine production and resulting
enhanced phagocyte recruitment.
We anticipated that, as a result of significantly reduced bacte-
rial burden within dLNs 24 hr after infection, Ccr2/ or Ccr7/
animals could have improved infection outcomes compared to
their wild-type controls. Therefore, we examined the spread of
bacteria to organs that are targets during systemic infection,
such as the lungs and the spleen, and survival during lethal chal-
lenge. For Ccr2/ mice there appeared to be a trend toward
reduced bacterial spread to systemic infection, since the mean
CFUs in the spleen and lungs 3 days after subcutaneous in-
fection seemed to be reduced; however, these reductions
were not statistically significant (Figure 3F). The mice did have
modestly but significantly prolonged survival after lethal chal-
lenge (Figure 3G), suggesting that CCR2-directed migration of
inflammatory monocytes is a contributing factor to Y. pestis
pathogenesis in vivo. In contrast, reductions in bacterial spread
to both the spleen and lungs in vivo after subcutaneous infection
in Ccr7/ mice were statistically significant compared to wild-
type (Figure 3H). Importantly, Ccr7/ mice had a significant
survival advantage and 60% of these mice recovered from
this otherwise lethal challenge (Figure 3I). The ability to use these
two individual mouse tools to promote survival emphasizes that
trafficking of multiple cellular subsets of phagocytic cells are
involved in the in vivo pathogenesis of Y. pestis. Since blockingmunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc. 443
Figure 3. CCR7- and CCR2-Directed Migration Enhance Y. pestis Virulence In Vivo
(A and B) Graph represents the total numbers of Y. pestis-infected cells (OFP+) within popliteal DLNs at 24 hr after infection with (A) Ccr2/mice and C57BL/6
controls or (B) Ccr7/ mice and BALB/c controls. The cell counts for OFP+ subsets that were single or double positive for surface markers CD11c and CD11b
were determined by flow cytometry. p < 0.0001 by two-way ANOVA.
(C) Relative CCL2 expression in dLNs, 24 hr after infection of C57BL/6 mice with Y. pestis. Mice were administered an anti-CCL21 or isotype control (IC) antibody
treatment 12 hr prior to infection. Real-time PCR data are representative of three independent experiments using RNA isolated from single LNs; p < 0.05 by
Student’s t test.
(D) Total numbers of CD11c+ cells in the dLNs of mice were determined by flow cytometry, 24 hr after Y. pestis infection and with pretreatment with either IC or
anti-CCL21 blocking antibody. Pretreatment with anti-CCL21 reduced the numbers of CD11c+ cells in dLNs; p < 0.05 by Student’s t test with n = 3.
(E) Significantly reduced CFUs were recovered from dLNs after pretreatment with anti-CCL21 blocking antibody compared to IC pretreatment, determined by
Student’s t test (p = 0.0006, n = 4).
(F) CFU data obtained day 3 after infection by isolating, homogenizing, and plating Y. pestis from spleen (left) or lung (right) tissue fromCcr2/ or C57BL/6 control
mice. Differences are not significant by ANOVA (p = 0.35); n = 6, pooled from two independent experiments. ND indicates not detected.
(G) Survival of Ccr2/ and C57BL/6 mice after subcutaneous infection with Y. pestis (n = 9–10, pooled from two independent experiments). Ccr2/ mice
survived significantly longer; p = 0.009.
(H) CFU data for the spleen (left) and lung (right) for Ccr7/mice and BALB/c controls. Differences are not significant by ANOVA (p = 0.06); n = 6–7, pooled from
two independent experiments.
(I) Survival of Ccr7/ and Balb/c mice after subcutaneous infection with Y. pestis (n = 5-10, pooled from 2 independent experiments). Ccr7/ mice survived
significantly longer; p = 0.0002. For all infections in this Figure, 13 105 CFU of Y. pestiswere injected in footpads forCcr2/ and C57BL/6 mice and 13 107 CFU
of Y. pestis were injected for Ccr7/ and Balb/c mice.
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sulted in significantly reduced dLN colonization (Figures 3A,
3B, and 3E) but for Ccr2/mice did not result in statistically sig-
nificant reductions in the numbers of bacteria colonizing distal
target organs under these experimental conditions (Figure 3F),
it seemed that multiple and/or redundant chemotactic pathways
had an additive effect in carrying the bacilli to LNs and distal
organs. Therefore, we began to investigate the events that allow
distribution of Y. pestis beyond the sentinel bubo and the role of
cellular trafficking in this event.
Intracellular Dissemination of Y. pestis through the
Lymphatic Vasculature
Because dLNs are highly vascularized, the bacilli might target
this organ to promote direct inoculation of the blood in LNs,
particularly since Y. pestis-infected LNs experience substantial
necrosis beginning in the early days of infection (Figure S1).
Despite the presence of growing necrotic lesions within
massively swollen LNs, the high endothelial venules in LNs ap-
peared intact in tissue sections and did not show any signs of
the vasculature having lost its barrier function to the blood (Fig-
ure S4). At 72 hr, numerous colonies of bacteria could be grown
from homogenates of the spleen and lungs of WT mice (Figures444 Immunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc.3F and 3H), signaling that a systemic infection had already been
established. Our alternate hypothesis is that phagocytes not only
facilitate the movement of bacteria into dLNs, but that, once
there, phagocytes also disseminate bacteria beyond the dLN
to downstream LNs, by traveling through lymphatics. The struc-
ture of the mammalian lymphatic vasculature is such that lymph
passes through sentinel dLNs and exits via the efferent lymph. It
then drains (along with any cellular constituents) to higher-order
LNs until finally this fluid is restored to circulation by the thoracic
duct. Cells morphologically consistent with both DCs and mac-
rophages have been isolated from the efferent lymph in the
thoracic duct (Anderson et al., 1981; Bell, 1979; De Martini
et al., 1983), raising the possibility that these recirculating cells
could be a direct route into the bloodstream for intracellular bac-
teria. To determine whether intracellular bacteria could be found
inside cells in transit between LNs, we performed confocal mi-
croscopy. After injection of OFP+Y. pestis into footpads, animals
were perfused with paraformaldehyde to preserve antigenic
integrity and the rear legs decalcified to promote sectioning
through the thigh tissue. Tissue sections were then stained for
CD11b (expressed by most infected cells in dLNs, Figure 2A)
and Lyve-1+ lymphatics. OFP+ bacilli could be viewed intracellu-
larly in CD11b+ cells within the postnodal lymphatics that depart
Figure 4. Intracellular Y. pestis Travel within
Lymphatics between LNs
(A) Merged and channel series staining of
mouse thigh tissue to show post-popliteal nodal
lymphatic vessels (Lyve-1, green), monocytes
(CD11b, blue), and OFP+ Y. pestis (red). Colocali-
zation reveals that some, but not all, CD11b+ cells
traveling in the postnodal lymphatics appear to
contain Y. pestis. Images are representative of
observations from two independent experiments
with two mice per group.
(B) Graph represents the percentage of Y. pestis
within the iliac node that are intracellular after
footpad infection with 1 3 105 CFU. Values were
obtained using a gentamicin protection assay, where a portion of the LN homogenate was treatedwith gentamicin to kill only the extracellular bacteria followed by
washing and treatment to lyse cells. The surviving intracellular fractionwas plated to determine the CFU, which is represented as a percentage of the total CFU for
the organ.
(C) Graph of total and intracellular Y. pestis, corresponding to (B). Blue shading illustrates the growth in numbers of extracellular bacteria over time by highlighting
the difference between total and intracellular bacterial counts. Data are representative of two independent experiments with n = 3–5 animals per group.
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transport of Y. pestis between LNs did occur. Furthermore, we
verified the presence of intracellular bacteria within the sec-
ond-order iliac node by performing a gentamicin protection
assay. The iliac node was processed to produce a single-cell
suspension followed by treatment with gentamicin to kill extra-
cellular bacteria, only including any that might be adherent to
the surface of cells. The CFUs of intracellular bacteria within
the iliac LN were then determined. When compared to the total
numbers of bacteria in the iliac LN, it became apparent that at
24 hr, more than 80% of Y. pestis in the iliac LN are intracellular,
a ratio that decreased over time after LN colonization (Figure 4B),
although total intracellular numbers continued to increase until
48 hr and subsequently declined (Figure 4C). This suggests
the role of the intracellular population in early sequential LN
colonization.
S1PReceptor Targeting to Limit Bacterial Spread In Vivo
Since our data using Ccr7/ or Ccr2/mice revealed that defi-
ciency for each chemokine receptor, individually, could not sub-
stantially prevent establishment of systemic Y. pestis infection,
we looked for another mechanism to impair trafficking to test
the hypothesis that Y. pestis reaches distant organs via intracel-
lular travel through the lymphatic system. For DCs, travel be-
tween LNs is thought to be dependent on S1P signaling, with
unique S1P receptors providing differential contributions to the
regulated egress of independent DC subsets from LNs (Rathi-
nasamy et al., 2010); however, less is known about the regulated
exit of non-DC monocytes from LNs, or whether this occurs. We
verified that the S1P receptor 1 (S1P1) was highly expressed on
both DP and SP populations of CD11b and CD11c stained cells
in LNs and footpads and found that even for CD11b+CD11c
cells, 98% of these cells also expressed S1P1 (Figures S5A
and S5B). Based on this, we employed the broadly acting S1P
receptor agonist, FTY720 (also known as Fingolimod), which
binds multiple S1P receptors to block cellular exit from LNs
(Brinkmann et al., 2002; Rivera et al., 2008). Prior to use, we veri-
fied that FTY720 did not have any direct bactericidal or bacterio-
static affect on Y. pestis by performing studies of growth kinetics
in vitro (data not shown). FTY720 also did not increase the
numbers of apoptotic cells in dLNs compared to vehicle aloneIm(Figures S5C and S5D). Mice were pretreated with FTY720
24 hr prior to subcutaneous infection with Y. pestis and, subse-
quent to infection, were treated daily. Since the iliac LNs are
higher-order nodes, which obtain efferent lymph that has passed
through the popliteal node, we examined these LNs for evidence
of altered Y. pestis trafficking during FTY720 administration. Af-
ter 24 hr, in FTY720-treated mice, total numbers of cells were
reduced compared to vehicle controls at baseline for all single-
or double-positive populations of CD11b/CD11c-stained cells
in both popliteal (Figure 5A) and iliac (Figure 5B) nodes. Similarly,
numbers of infected phagocytes, defined as OFP+, were sub-
stantially reduced in the popliteal (Figure 5C) and iliac (Figure 5D)
LNs for FTY720-treated mice, compared to mice administered
the drug vehicle. As expected based on the results in Figure 2A,
only a very small minority of infected cells were CD11c SP (data
not shown). This trend that FTY720 reduced total cellularity of
CD11b+ and CD11c+ cells was continued at 48 hr (Figure S5E).
We also performed a CFSE-labeling experiment to track travel
of infected cells from the site of instillation and through LNs.
For this, CFSE was injected into footpads prior to infection
with Y. pestis and flow cytometry was performed from single-
cell suspensions of LNs after 24 hr to quantify the numbers of
YP-OFP+ and CFSE+ cells in the LNs of FTY720-treated animals,
compared to vehicle-treated animals. These results revealed
that just as FTY720 treatment can act to reduce many subsets
of infected and uninfected cells within primary and secondary
order LNs (Figures 5A–5D), the accumulation in LNs of
footpad-derived infected cells, which are presumably a key
founder population in sequential LN colonization, is also sub-
stantially blocked (Figures 5E and 5F). Background levels of
travel of CFSE-labeled cells were not detected within LNs
outside of the context of infection (data not shown). Interestingly,
with infection, CFSE-labeled cells made their way to iliac nodes,
signifying that within 24 hr, infected cells can transit completely
through the dLN (Figure 5F).
Because FTY720 is best described for its effective inhibition of
T cell recirculation through lymphoid organs (Matloubian et al.,
2004), we also verified that the observed effect of FTY720 in
reducing infected DCs and monocytes within dLNs was not
dependent on T cells. T cell depletion by antibody was chosen
as a strategy over the use of nude mice since the latter lackmunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc. 445
Figure 5. S1P Promotes Y. pestis Dissemination through Lymphoid Tissue
Animals were pretreated 24 hr before infection and then administered a daily regimen of S1P-agonist FTY720 or vehicle.
(A and B) Graphs represent the total numbers of cells staining single- (SP) and double-positive (DP) for markers CD11b and CD11c in the dLN, the popliteal LN (A)
or in iliac LNs distal to dLNs (B) 24 hr after infection with Y. pestis.
(C and D) Graphs represent the number of cells infected by Y. pestis in the popliteal (C) and iliac (D) LNs, after gating on the OFP+ population. Infected
CD11bCD11c+ were not detected in iliac nodes at 24 hr.
(E and F) The graphs represent the numbers of footpad-derived cells in popliteal (E) and iliac (F) LNs that were infected with Y. pestis, by gating on cells CFSE+ and
OFP+. CFSE labeling was performed 4 hr prior to infection with Y. pestis expressing OFP.
(G and H) Graphs depict numbers of CD11b+CD11c+/ cells within popliteal (G) and iliac (H) LNs of mice depleted of T cells prior to infection and treatment with
FTY720 or vehicle control.
(I) The CFU counts from the spleens and lungs, harvested day 3 of infection, from animals treated with FTY720 or vehicle are presented.
(J and K) Graphs represent the total number of cells with phenotypes SP or DP for CD11b and CD11c in popliteal (J) or iliac (K) LNs, 24 hr after infection and with
treatment with S1P1 receptor agonist SEW2871.
(L and M) Numbers of footpad-derived cells (CFSE+OFP+) in the popliteal (L) and iliac LNs (M) after SEW2871 treatment or vehicle control.
(N and O) CFUs were determined in the popliteal LN (N) and iliac LN (O), 24 hr after infection, as above.
For (A)–(H) and (J)–(M), significance was determined by Student’s unpaired t test; *p% 0.05. n = 3–6 per group. For (I), significance was determined by 2-way
ANOVA; p < 0.0001. For (N) and (O), p < 0.05 by 1-way ANOVA with Bonferroni’s post-test.
(P) Mice were monitored for survival after infection with Y. pestis and treatment with FTY720, SEW2871, or vehicle control (n = 5–10 per group). Survival curves of
infected mice treated with FTY720 and SEW2871 both differed significantly from the survival curve of mice treated with vehicle alone (p = 0.04 and 0.01,
respectively, by log-rank test). Surviving proportions also differed significantly; p = 0.04 and 0.01, respectively, by Fisher’s exact test.
Immunity
S1P-Dependent Trafficking of Yersinia pestisT cells but also have describedmorphological defects within LNs
(Sainte-Marie and Peng, 1983). After successful depletion of
>98% of T cells (data not shown), followed by FTY720 treatment
and infection, FTY720 still effectively reduced the numbers of
CD11b SP and CD11c+CD11b+ cells within popliteal (Figure 5G)
and iliac (Figure 5H) LNs in the absence of T cells. Additionally,
when bacterial burden was assessed in the lungs and the
spleens of infected mice 3 days after infection, we observed
that FTY720 also dramatically reduced the numbers of bacteria
in these organs (Figure 5I). To support a role for S1P receptors
in the dissemination of Y. pestis-infected cells in vivo, we used
a second compound, SEW2871, which is considered to be a
specific agonist of S1P1 (Rivera et al., 2008). Treatment of ani-
mals with SEW2871 resulted in reduced numbers of infected
cells in the iliac but not popliteal LNs, implicating S1P1 specif-
ically in the travel of infected cells between LNs, but not in the
initial event of dLN colonization (Figures 5J and 5K). Similarly,446 Immunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc.pretreatment of footpads with CFSE to label cells demonstrated
that this generalized observation can be extended to those cells
that were footpad resident and that became infected with
YP-OFP, where SEW2871 did not reduce the total numbers of
OFP+CFSE+ within the popliteal LN, but did reduce the total
numbers in iliac LNs, compared to vehicle controls (Figures 5L
and 5M). This suggests that other S1P receptors can compen-
sate for inhibition of S1P1 during the initial colonization of the
dLN during S1P1-specific blockade. For example, most infected
DCs in the footpad and dLN expressed S1P3 (Figures S5E–S5G).
Since our data pertaining to FTY720 and SEW2871 focused on
examining the influence of these drugs on the trafficking patterns
of infected cells, we also confirmed that consistent results were
obtained in terms of total CFU in LNs. In agreement with data for
infected cell populations, FTY720 significantly reduced Y. pestis
CFU in both popliteal (Figure 5N) and iliac (Figure 5O) LNs, while
SEW2871 did not influence CFUs in popliteal LNs (Figure 5N),
Figure 6. Conditional Deletion of S1P1 in Mononuclear Phagocytes Limits Intranodal Y. pestis Spread
(A) S1P1 expression on CX3CR1
+ and CX3CR1 cells in CX3CR1-Cre S1P1
fl/fl mice compared to CX3CR1-Cre S1P1
+/+ littermate controls, determined by flow
cytometry.
(B) The graphs represent the numbers of cells in popliteal and iliac LNs that were infected with Y. pestis, by gating on OFP+ cells. Statistics were performed by 2-
way ANOVA, where n = 4 mice per group (p < 0.01). Not significant = ns. Data are representative of two independent experiments.
(C) Survival of CX3CR1-Cre S1P1
fl/fl and CX3CR1-Cre S1P1
+/+ littermate controls (n = 7–9) after footpad infection with 13 105 CFU of Y. pestis; p = 0.01 by log-rank
test.
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support of the importance of node-to-node travel in the estab-
lishment of systemic infection, both FTY720 and SEW2871
(Figure 5P) treatment promoted survival of challenged mice.
Therefore, blocking the intranodal trafficking of infected cells
by targeting the S1P pathway offers substantial protection
from Y. pestis.
S1P1 on Mononuclear Phagocytes Permits Y. pestis Exit
from dLNs
To corroborate the drug studies that we performed and
further interrogate the role of S1P1 in intranodal trafficking by
Y. pestis-infected mononuclear phagocytes, we generated con-
ditional gene-deletion mice with S1P1 deleted in CX3CR1-ex-
pressing cells. The mouse strain with CX3CR1-driven cre ex-
pression was chosen since this chemokine receptor is broadly
expressed within the monuclear phagocyte system (Yona
et al., 2013). These mice were bred to mice with the S1P1
locus flanked by loxP sites. We first validated that there was
efficient functional deletion resulting in loss of surface expres-
sion of S1P1 on CX3CR1
+ cells, specifically, by performing
flow cytometry to assess the expression of S1P1 on CX3CR1
+
cells compared to CX3CR1 cells as an internal control. Mice
carrying the floxed allele (Cx3cr1-Cre S1pr1fl/fl) showed efficient
deletion, whereas littermate control mice (Cx3cr1-Cre S1pr1+/+)
had expression of S1P1 on CX3CR1
+ cells (Figure 6A). No alter-
ations in the cellularity of LNs were observed at the steady state
in Cx3cr1-Cre S1pr1fl/fl compared to Cx3cr1-Cre S1pr1+/+ con-
trols (Figure S6). We observed that 24 hr after infection with
Y. pestis, numbers of intracellular bacteria were substantially
decreased in secondary iliac LNs in Cx3cr1-Cre S1pr1fl/fl mice
compared to Cx3cr1-Cre S1pr1+/+ controls (Figure 6B). Similar
to our prior observations that other S1P receptors can compen-
sate for any utilization of S1P1 by infected cells for travel to DLNs
(Figure 5), we did not observe a significant reduction in the
numbers of Y. pestis-containing cells in the primary poplitealImLN at 24 hr after infection (Figure 6B). In support of the impor-
tance of S1P1 on mononuclear phagocytes to Y. pestis dissem-
ination through the lymphatic system, we observed that
Y. pestis-infected Cx3cr1-Cre S1pr1fl/fl mice had significantly
reduced mortality compared to Cx3cr1-Cre S1pr1+/+ controls
after subcutaneous inoculation of bacteria (Figure 6C). Our re-
sults show that S1P1 expression is important for trafficking of
Y. pestis-infected cells from primary to secondary LNs after
peripheral infection and that this process of dissemination has
consequences for survival.
DISCUSSION
These studies expose the role of the lymphatic system as a
conduit for virulent pathogens to achieve systemic infection
and reveal the underlying mechanism behind bubo formation
during Y. pestis infection to be dependent on the chemotaxis
of multiple subsets of DCs and monocytes. Furthermore, we
show that Y. pestis is able to capitalize on the host’s chemo-
tactic pathways to travel to and within lymphoid tissue, first,
by exploiting cellular trafficking of DCs to colonize dLNs as
an intracellular, founder population and then by promoting
cellular trafficking of additional DCs and inflammatory mono-
cytes into LNs. This occurs based on the upregulation of a
broad panel of chemokines, including CCL2 and others, and
use of the S1P receptors to travel to dLNs. Our results also
emphasize the importance of the S1P1 receptor, specifically,
for guiding infected mononuclear phagocytes between the pri-
mary draining LN and secondary LNs. Conditional gene-
deleted mice that lack the S1P1 receptor on CX3CR1
+ cells,
which are myeloid lineage mononuclear phagocytes (Yona
et al., 2013), have significantly diminished spread of intracel-
lular Y. pestis to the second order LNs in our model, the iliac
nodes, while the numbers of bacteria in the popliteal, or primary
dLN, are not significantly influenced. S1P1-mediated dissemi-
nation of Y. pestis reduces survival during infection sincemunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc. 447
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fl/fl mice are more resistant to Y. pestis-asso-
ciated death than littermate controls.
CCL21 promotes the initial egress of DCs to the LNs from
sites of infection and is required for subsequent upregulation
of monocyte chemoattractants within LNs. CCL21 blockade
also significantly reduces the number of bacteria in the dLN in
the first 24 hr of infection, emphasizing the adverse functional
consequences of the travel of DCs in promoting the initial colo-
nization of LNs with Y. pestis. This suggests that the original
migrating DCs from the site of infection containing intracellular
bacteria play an important role in establishing infection in the
dLN. We also observe that there is significantly decreased bac-
terial spread to the lungs and spleen and increased survival of
mice lacking CCR7, further emphasizing this key DC chemo-
tactic pathway involving CCL21 and CCR7 in Y. pestis patho-
genesis. Once cells are infected peripherally, cellular trafficking
into the dLN as a second site of infection is further augmented
by increased chemokine production within dLNs. Our results
also suggest that this process is promoted by S1P receptors
since FTY720 treatment can dramatically reduce the numbers
of infected cells in dLNs. In addition to the possibility that mono-
cyte chemoattractants could promote subsequent colonizations
by peripherally infected cells, they may, alternatively, promote
the arrival of uninfected cells in LNs that could be infected by
those bacteria that are already there, allowing additional in situ
intracellular replication of Y. pestis. There is a shift in the cell
type that is predominantly infected beginning around 48 hr after
infection, so that most infected cells are non-DC cell types, ex-
pressing the marker CD11b, which are primarily monocytes and
neutrophils that have phagocytosed bacteria. Monocytes have
long been recognized to be able to be infected by Y. pestis
and here we demonstrate, through the use of CCR2-deficient
mice, that their recruitment is also consequential to disease
progression, promoting bubo formation and hastening death.
We note, however, that a caveat to use of Ccr2/ mice is the
complication that they also have reduced monocyte egress
from the bone marrow (Tsou et al., 2007). Although the effects
of chemokine receptor deficiency are significant, they are also
modest in comparison to S1P blockade, presumably since mul-
tiple inflammatory cytokines with monocyte- or macrophage-re-
cruiting functions are induced that may serve a redundant func-
tion. The proinflammatory factors produced by inflammatory
monocytes may also amplify the recruitment of additional DCs
and monocytes through the site of infection and to dLNs. The
possibility exists that other defects in these knockout mice,
such as altered efflux of cells from the bone marrow or entry
into the tissue site likely contribute to the phenotypes observed
and this is an important caveat to ascribing function to a unique
chemotactic response in distributing Y. pestis systemically.
Interestingly, for additional bacterial infections, including Listeria
monocytogenes, Brucella melitensis, andMycobacterium tuber-
culosis, CCR2-mediated recruitment of cells serves a protective
role for the host (Shi and Pamer, 2011), while in other infectious
contexts, including viral and parasitic infections, CCR2-medi-
ated recruitment has been associated with pathology at
the site of infection (Shi and Pamer, 2011). We observe that
the strong upregulation of monocyte chemoattractants during
Y. pestis infection within LNs drastically contrasts with the tran-
scriptional programs that occur during infections by other Gram-448 Immunity 41, 440–450, September 18, 2014 ª2014 Elsevier Inc.negative bacteria. This is a site where infection and inflammatory
responses directed at the tissue have hardly been inspected.
Buboes have primarily been examined in the terminal stages
of infection when they are already structures defined by overt
pathology that is distinguishable from resting or even inflamed
dLNs in terms of size, cellularity, and tissue viability (Sebbane
et al., 2006a, 2006b). Our results suggest that bubo formation
is a process that begins in the earliest hours of infection and
one that is integral to the virulence of Y. pestis, allowing the
quick progression of bacteria from a site of subcutaneous injec-
tion to systemic infection, which would be more conducive to
host-to-host transmission.
Since, here, we have used a strain of Y. pestis that should have
a reduced growth rate in peripheral tissues where iron is low,
these processes may be hastened during the pathogenesis of
wild-type Y. pestis.Due to its reduced virulence in vivo by periph-
eral routes, the Kim5 strain has not previously been used as a
model of bubonic plague, although other groups have also re-
ported that it can be lethal to mice after peripheral inoculation
(Perry and Fetherston, 1997; Une and Brubaker, 1984). In spite
of the accepted observation that mice are more resistant to
Kim5 or other strains lacking the pigmentation locus than WT
Y. pestis strains, this strain may be useful for studying the immu-
nological responses to Y. pestis since it also provokes bubo for-
mation and allows host survival for several days even at lethal
doses.
Blocking of cellular egress from LNs with FTY720, or with
similar drugs targeting the S1P pathway, is a highly promising
therapy that has been employed successfully experimentally in
additional contexts of inflammation such as to limit autoimmune
conditions (Takabe et al., 2008). In these contexts, the functional
effects are assumed to predominately be based on the role of
S1P agonists in blocking the regulated departure of lymphocytes
from LNs (Rosen andGoetzl, 2005; Takabe et al., 2008), although
our data suggest that the actions of S1P agonists in reducing
Y. pestis in vivo are not attributable to the described role of these
drugs on T cells (Matloubian et al., 2004). With S1P agonist treat-
ment, we see that multiple subsets of monocytic cells can also
be targeted for retention in peripheral LNs. In the case of
Y. pestis infection, FTY720 can be used to slow the advance of
the disease from the tissue to dLN, from dLNs to higher-order
LNs that collect lymph from multiple sentinel LNs, as well as to
the more readily transmitted septicemic or pneumonic forms of
infection. This suggests that passive dissemination of extracel-
lular bacteria by lymph flow, as has been alluded to as a possible
mechanism of bacterial spread based on the presence of extra-
cellular Y. pestis within organs (Pujol and Bliska, 2005), is not as
important in this infection as the route of intracellular trafficking.
Like others, we have also observed that many Y. pestis are found
extracellularly in buboes (Sebbane et al., 2005); however, this
extracellular population becomes more abundant after LN colo-
nization, following an initial phase where the intracellular popula-
tion is dominant. Unique S1P receptors govern independent
phases of the transition from peripheral to systemic infection
since the S1P1-specific agonist, SEW2871, does not influence
the number of bacteria that are able to invade to the dLN, but still
reduces node-to-node travel of intracellular Y. pestis. In support,
we observe that mice with a conditional knockout of S1P1 in
CX3CR1-expressing cells have reduced spread of bacteria to
Immunity
S1P-Dependent Trafficking of Yersinia pestissecondary LNs. This is consistent with the observations of others
that DC travel to dLNs is dependent on differential S1P receptors
depending on the tissue or origin and DC subset. However, in
contrast to our findings, those studies using sterile inflammatory
stimuli also suggested that travel of tissue-resident DCs to dLNs
was primarily dependent on S1P1 (Gollmann et al., 2008; Lamana
et al., 2011; Rathinasamy et al., 2010). This raises the possibility
that the nature of inflammatory stimulus may also influence the
capacity of DCs or other subsets of phagocytic cells to home
to dLNs in a manner dependent on individual S1P receptors.
We also observed that S1P1 deficiency on CX3CR1
+ cells did
not appear to significantly influence LN cellularity in the resting
state, further emphasizing the importance of the inflammatory
context to cellular trafficking. We expect that slowing the spread
of intracellular hijacking bacteria could not only alter the disease
outcome for an individual, but could potentially limit disease pro-
gression within a host population since colonization of target or-
gans such the lungs is associated with virulent bacterial spread.
This application of S1P agonists may be of utility in targeting
additional intracellular or lymphotrophic pathogens.
EXPERIMENTAL PROCEDURES
Mice
Six-week-old female C57BL/6 were purchased from the National Cancer
Institute Animal Production Area. Ccr2/ mice (C57BL/6 background) and
Ccr7/ mice (BALB/c background) were maintained in the Duke University
Vivarium. All animals were housed at the Duke University Vivarium and proto-
cols were approved by the Duke University Institutional Animal Care and Use
Committee.
Bacterial Cultures and Infections
Cultures of S. typhimurium SL1344 and E. coli J96 were grown overnight in LB
(Difco Laboratories) at 37C. Cultures of Y. pestis Kim5 were grown 48–72 hr in
brain heart infusion (BHI) broth (Fluka Analytical), under shaking conditions at
room temperature. To generate strains of fluorescent Y. pestis Kim5, bacteria
were transfected by electroporesis with plasmid containing the OFP gene and
an antibiotic marker, followed by selection of colonies on antibiotic (Ampicillin)
plates. For footpad injections, 1 3 105 CFU (C57BL/6 background) or 13 107
CFU (BALB/c background) of bacteria were injected in a 20 ml volume of sterile
PBS. To determine CFUs in organs, infected mice were euthanized at the
noted time points after infection and organs were harvested and the mass re-
corded. Tissues were then homogenized in sterile water using ceramic beads
for 2 cycles of 60 s each using an automatic homogenizer. Homogenates were
plated on BHI plates and the colonies were counted after 48–72 hr incubation
at room temperature in order to calculate the CFU of whole organs or relative to
the biopsy mass. For survival curves, infected animals were monitored every
12 hr for death or humane endpoints.
Fingolimod Preparation and Treatment
Fingolimod (also known as FTY720) or SEW2817 (both from Cayman Chemi-
cals) were dissolved to 25 mg/ml in DMSO for storage at 80C and diluted
in sterile 2% hydroxypropyl-b-cyclodextrin (w/v) in PBS for injections. Mice
were given 5 mg/kg of FTY720 or SEW2817 or an equivalent amount of vehicle
i.p. starting 12 hr before infection and then every 24 hr after infection.
Statistical Analysis
Significance was determined by unpaired two-tailed Student’s t tests to
assess data where only two groups existed, or by one- or two-way ANOVA,
as appropriate. The Dunnett post test was used to acquire p valueswhen treat-
ments were compared to the control alone. Significance for Kaplan-Meier
Curves was determined by the log-rank test and Fisher’s exact test was
used to evaluate significance in the surviving proportions. Statistics were per-
formed using Excel and Prism software.ImSUPPLEMENTAL INFORMATION
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